この記事を読む

KRAS G12Cに対するソトラシブの2年追跡結果

Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non-Smal…

この記事を読む

EGFR遺伝子変異陽性に対するPACIFICレジメン

Durvalumab After Chemoradiotherapy in Unresectable StageⅢ EGFR-Mutant NSCLC: A Post Hoc Subgroup Analysis From PACIFIC. …

この記事を読む

TTF-1別に免疫複合療法もレジメン選択をすべきか?

Clinical Outcomes of Combined Chemoimmunotherapy in Patients With Advanced Lung Adenocarcinoma: A Prospective Observatio…

この記事を読む

免疫複合療法後の化学療法

Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanc…

この記事を読む

自己申告での喫煙・非喫煙は遺伝子レベルでは少し乖離

Tobacco Smoking-Related Mutational Signatures in Classifying Smoking-Associated and Nonsmoking-Associated NSCLC. Ernst S…

この記事を読む

SBRT後の遠隔転移の予測モデル

Prediction of Distant Metastases After Stereotactic Body Radiation Therapy for Early Stage NSCLC: Development and Extern…

この記事を読む

術前免疫療法後のPETでMPRを予測する

Utility of 18F-FDG PET/CT uptake values in predicting response to neoadjuvant chemoimmunotherapy in resectable non-small…

この記事を読む

ニボルマブ+イピリムマブの長期成績

Long-term survival with first-line nivolumab plus ipilimumab in patients with advanced non-small-cell lung cancer: a poo…

この記事を読む

TKI使用後T790M陰性に対するオシメルチニブ

A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation-positive NSCLC in who…

この記事を読む

免疫チェックポイント阻害薬と肝炎ウイルス感染

Immune Checkpoint Inhibitors in Patients With Cancer and Infection by Hepatitis B or C Virus: A Perspective Through the …